From Prototype to Profit: Commercialization Insights

A new study values the retail prop-trading ecosystem at $20 billion, but with 93% of traders failing to get a payout, is it democratizing finance or a gamble?

Wildflower Health's acquisition of Every Mother signals a major shift, moving vital pelvic floor care from a niche service to a standard part of maternal health.

With key hires from Ceridian and Mitratech, Tungsten Automation doubles down on its AI-first strategy, partner ecosystem, and expansion in Asia.

duPont REGISTRY's move to acquire Earth Motorcars signals a bold shift from media brand to an experiential empire, reshaping the luxury auto landscape.

With its stock at a low and a new CEO at the helm, Gulfport Energy's upcoming Q2 results will be a crucial test of its strategy amid a volatile gas market.

Unprecedented swings in gold have ignited a retail trading frenzy in commodities. We analyze the market forces and the platforms capitalizing on this shift.

As shelters face a deluge of kittens, a look inside the powerful partnership of retail, non-profits, and corporate sponsors turning store aisles into lifelines.

HC Pacific’s rebrand to Proponent Defense signals a major shift, leveraging global commercial logistics to redefine military readiness and aftermarket support.

DNRS, a brain retraining program, has shed its fragmented legacy system. We analyze how 9thCO's composable architecture provides a blueprint for commercial success.

As senior financial fraud losses soar 60%, Fairway Home Mortgage launches Fairway SAFE, a nonprofit aimed at protecting older adults through education.

As AI's energy thirst threatens to stall growth, Intrinsic Power has secured key funding to commercialize its AI platform that orchestrates power for data centers.

With a 116% portfolio jump since 2023 and 32% rent growth, INDUS Realty's mid-year results reveal more than just success; they show a powerful market play.

As Corrixr's novel CRISPR therapy nears human trials, the appointment of Seagen veteran Nancy Whiting signals a strategic shift from lab to market.

New American Funding partners with AI-native Vesta to slash loan times and costs, a move set to enhance customer service and pressure competitors to modernize.

Worthington Steel moves to take full control of German metals giant Kloeckner & Co, launching a delisting offer that puts shareholders at a crossroads.

With industry pioneer Michael Rigas on board, Infusion for Health's expansion into home infusion signals a major shift toward decentralized, patient-centric care.

Padder's guarantor-as-a-service model, designed to help non-traditional renters, won a major grant, signaling a fintech shift in solving Canada's housing woes.

Telana renews its exclusive Microsoft Azure Expert MSP status, validating its model for freeing UK firms from operational toil to drive tangible, AI-led growth.

AB grew AUM to $905B not through market luck, but through inflows. We unpack the strategy, from passive mandates to retail strength, that works in neutral markets.

Milla Pharmaceuticals' new FDA approval for a vital acidosis drug offers hope for hospitals battling chronic shortages and marks a key strategic win for parent A.forall.